3 insiders reported 49 Form 4 transactions for Contineum Therapeutics, Inc. (CTNM) over the past 18 months (most recent 2026-08-03). Recent activity: Stengone Carmine N. (CEO and President) Sell 2,500 shares, Stengone Carmine N. (CEO and President) Buy 2,500 shares, Lorrain Daniel S. (Chief Scientific Officer) Buy 1,015 shares, Lorrain Daniel S. (Chief Scientific Officer) Sell 1,015 shares, Lorrain Daniel S. (Chief Scientific Officer) Buy 25 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-03 | Stengone Carmine N. | CEO and President | Sell | 2,500 | $40,029 |
| 2026-08-03 | Stengone Carmine N. | CEO and President | Buy | 2,500 | $2,525 |
| 2026-07-10 | Lorrain Daniel S. | Chief Scientific Officer | Buy | 1,015 | $1,025 |
| 2026-07-10 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 1,015 | $16,240 |
| 2026-07-10 | Lorrain Daniel S. | Chief Scientific Officer | Buy | 25 | $25 |
| 2026-07-10 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 25 | $400 |
| 2026-07-08 | Stengone Carmine N. | CEO and President | Sell | 2,500 | $40,000 |
| 2026-07-08 | Stengone Carmine N. | CEO and President | Buy | 2,500 | $2,525 |
| 2026-07-02 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 2,501 | $40,608 |
| 2026-07-02 | Lorrain Daniel S. | Chief Scientific Officer | Buy | 28,826 | $29,114 |
| 2026-07-02 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 28,826 | $462,288 |
| 2026-07-02 | Lorrain Daniel S. | Chief Scientific Officer | Buy | 4,183 | $4,225 |
| 2026-07-02 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 5,852 | $91,682 |
| 2026-07-01 | Stengone Carmine N. | CEO and President | Buy | 7,500 | $7,575 |
| 2026-07-01 | Watkins Tim | CMO & Head of Development | Buy | 10,833 | $48,748 |
| 2026-07-01 | Stengone Carmine N. | CEO and President | Buy | 2,500 | $3,150 |
| 2026-07-01 | Watkins Tim | CMO & Head of Development | Sell | 10,833 | $173,590 |
| 2026-07-01 | Stengone Carmine N. | CEO and President | Sell | 10,000 | $160,080 |
| 2026-06-01 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 4,170 | $54,862 |
| 2026-05-01 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 300 | $4,152 |
| 2026-05-01 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 3,870 | $50,542 |
| 2026-04-06 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 4,170 | $56,014 |
| 2026-03-02 | Lorrain Daniel S. | Chief Scientific Officer | Sell | 4,170 | $62,592 |
| 2026-03-02 | Watkins Tim | CMO & Head of Development | Buy | 3,611 | $16,250 |
| 2026-03-02 | Watkins Tim | CMO & Head of Development | Sell | 3,611 | $54,237 |
Source: SEC Form 4 filings · as of 2026-08-03